A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CE-MRA / contrast-enhanced MR angiography

[Related PubMed/MEDLINE]
Total Number of Papers: 156
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CE-MRA  (>> Co-occurring Abbreviation)
Long Form:   contrast-enhanced MR angiography
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension. PH, RHC, ROI, rPTT, WHO
2021 Automated segmentation of the individual branches of the carotid arteries in contrast-enhanced MR angiography using DeepMedic. DSC, MCC, SCAPIS, TPR
2021 ECG-gated MR angiography provides better reproducibility for standard aortic measurements. AAo, DAo, DLSA, SOV
2020 Comparison of Contrast Enhanced Magnetic Resonance Angiography to Computed Tomography in Detecting Pulmonary Arteriovenous Malformations. CT, FAD, MR, TTCE
2020 New technique: the use of the THRIVE sequence in the follow-up of patients who received endovascular intracranial aneurysm treatment. MIP, THRIVE, TOF-MRA
2020 Peri-thrombus vascular hyperintensity sign: detection of intracranial thrombus location and length in acute ischemic stroke. AIS, BB, PVHS
2020 Towards Automated Quantification of Vessel Wall Composition Using MRI. CAs, FF, IPH, LRNC, SCAPIS, SVM
2019 Different CMR Imaging Modalities for Native and Patch-Repaired Right Ventricular Outflow Tract Sizing: Impact on Percutaneous Pulmonary Valve Replacement Planning. CMR, PR, RVOT
2019 Evaluation of four injection profiles for uniform contrast-enhanced signal intensity profiles in MR angiography. DB, DS, SI
10  2019 Feasibility and relevance of discrete vasculature modeling in routine hyperthermia treatment planning. CT, DIVA, HTP, MRI, PBHE
11  2018 Evaluation of Quiescent-Interval Single-Shot Magnetic Resonance Angiography in Diabetic Patients With Critical Limb Ischemia Undergoing Digital Subtraction Angiography: Comparison With Contrast-Enhanced Magnetic Resonance Angiography With Calf Compression at 3.0 Tesla. CLI, DSA, QISS-MRA
12  2018 Noncontrast MR angiography: An update. CT
13  2018 Recent advances in magnetic resonance imaging for peripheral artery disease. ASL, BOLD, MRI, PAD
14  2017 Intracranial Aneurysms Treated by Flow-Diverting Stents: Long-Term Follow-Up with Contrast-Enhanced Magnetic Resonance Angiography. DSA
15  2017 Knee subchondral bone perfusion and its relationship to marrow fat and trabeculation on multi-parametric MRI and micro-CT in experimental CKD. CKD, DCE-MRI, FF, MRS, WF
16  2017 Nonenhanced MR angiography of the pulmonary arteries using single-shot radial quiescent-interval slice-selective (QISS): a technical feasibility study. CTA, QISS
17  2017 Segmentation of lumen and outer wall of abdominal aortic aneurysms from 3D black-blood MRI with a registration based geodesic active contour model. MR
18  2016 Comparison of imaging value for diabetic lower extremity arterial disease between FBI and CE-MRA. DLEAD, DM, FBI, PAD
19  2016 Effects of Imaging Parameters on the Quality of Contrast-Enhanced MR Angiography of Cerebral Aneurysms Treated Using Stent-Assisted Coiling: A Phantom Study. ALN, BW, FA, FS, IS/N, RISC, RISS, TE
20  2016 High-resolution dynamic CE-MRA of the thorax enabled by iterative TWIST reconstruction. ---
21  2016 Middle cerebral artery stenosis in patients with nasopharyngeal carcinoma after radiotherapy: the incidence of stenosis and the risk factors. MCA, NPC
22  2016 Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study. LVEF, MR, PAD, PWV
23  2015 Carotid and vertebral artery stenosis evaluated by contrast-enhanced MR angiography in nasopharyngeal carcinoma patients after radiotherapy: a prospective cohort study. CA, CCA, CCA/ICA, ICA, NPC, VA
24  2015 Evaluation of CTA, time-resolved 4D CE-MRA and DSA in the follow-up of an intracranial aneurysm treated with a flow diverter stent: Experience from a single case. CTA, DSA
25  2015 Follow-up of intracranial aneurysms treated by a WEB flow disrupter: a comparative study of DSA and contrast-enhanced MR angiography. IAs
26  2015 Noncontrast MR angiography (MRA) of infragenual arteries using flow-sensitive dephasing (FSD)-prepared steady-state free precession (SSFP) at 3.0 Tesla: Comparison with contrast-enhanced MRA. FSD, MRA, rSI, SSFP
27  2015 Site-specific association between distal aortic pulse wave velocity and peripheral arterial stenosis severity: a prospective cardiovascular magnetic resonance study. CMR, NWI, PAOD, PWV
28  2014 3D morphometry using automated aortic segmentation in native MR angiography: an alternative to contrast enhanced MRA? MRA, N-MRA
29  2014 Carotid Artery Stenosis: Comparison of 3D Time-of-Flight MR Angiography and Contrast-Enhanced MR Angiography at 3T. TOF-MRA
30  2014 Detection of infragenual arterial disease using non-contrast-enhanced MR angiography in patients with diabetes. FSD, NCE-MRA, SSFP
31  2014 Follow-up of intracranial aneurysms treated by flow diverter: comparison of three-dimensional time-of-flight MR angiography (3D-TOF-MRA) and contrast-enhanced MR angiography (CE-MRA) sequences with digital subtraction angiography as the gold standard. DSA
32  2014 Noncontrast-enhanced magnetic resonance renal angiography using a repetitive artery and venous labelling technique at 3 T: comparison with contrast-enhanced magnetic resonance angiography in subjects with normal renal function. NC-MRA, RAVEL
33  2014 Patency of runoff detected by MR angiography at 3.0 T with cuff-compression: a predictor of successful endovascular recanalization below the knee. ABI, BTK, CLI, DSA, ER
34  2014 Role of non-contrast balanced steady-state free precession megnetic resonance angiography compared to contrast-enhanced megnetic resonance angiography in diagnosing renal artery stenosis: a meta-analysis. AUC, b-SSFP MRA, CI, DOR, NC-MRA, NLR, PLR, RAS, ROC, SEN, SROC
35  2014 Selection and evaluation of optimal two-dimensional CAIPIRINHA kernels applied to time-resolved three-dimensional CE-MRA. g-factor, SNR
36  2014 The accuracy and utility of contrast-enhanced MR angiography for localization of spinal dural arteriovenous fistulas: the Toronto experience. DSA, SDAVF
37  2013 An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography. ---
38  2013 Artifactual aortic coarctation: a processing error in aortic magnetic resonance angiography. MIPs, MR
39  2013 Comparison of quiescent inflow single-shot and native space for nonenhanced peripheral MR angiography. QISS
40  2013 High spatial and temporal resolution dynamic contrast-enhanced magnetic resonance angiography using compressed sensing with magnitude image subtraction. CS
41  2013 Human whole-blood (1)H2O longitudinal relaxation with normal and high-relaxivity contrast reagents: influence of trans-cell-membrane water exchange. CR
42  2012 Artificial luminal narrowing on contrast-enhanced magnetic resonance angiograms on an occasion of stent-assisted coiling of intracranial aneurysm: in vitro comparison using two different stents with variable imaging parameters. ALN
43  2012 CE-MRA for follow-up of aneurysms post stent-assisted coiling. ---
44  2012 Comparison of contrast-enhanced multi-station MR angiography and digital subtraction angiography of the lower extremity arterial disease. DSA
45  2012 Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations. SNR
46  2012 MR angiography of carotid artery aneurysms in a porcine model at 3 Tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques. CNR
47  2012 Unenhanced MR angiography of renal arteries: 51 patients. NPV, RAS, SMA, SSFP
48  2011 Arterial flow characteristics in the presence of vascular disease and implications for fast spin echo-based noncontrast MR angiography. FSE, NC-MRA
49  2011 Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. CTE, CTPA
50  2011 Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH, DSA, MDCTA
51  2011 Effects of cardiac motion on 3D contrast-enhanced MR angiography of the carotid arteries. ---
52  2011 Evaluation of inflammatory status of atherosclerotic carotid plaque before thromboendarterectomy using delayed contrast-enhanced subtracted images after magnetic resonance angiography. CPCE, ICI, T1W-GRE
53  2011 High spatial and temporal resolution imaging of the arterial vasculature of the lower extremity with contrast enhanced MR angiography. CAPR
54  2011 High-resolution MRI of carotid plaque with a neurovascular coil and contrast-enhanced MR angiography: one-stop shopping for the comprehensive assessment of carotid atherosclerosis. IPH, NPV, PPV
55  2011 Iatrogenic neonatal type B aortic dissection: comprehensive MRI-based diagnosis and follow-up. ---
56  2011 Non-contrast MRA using an inflow-enhanced, inversion recovery SSFP technique in pediatric abdominal imaging. bSSFP, NC
57  2011 Peripheral arterial disease in a symptomatic diabetic population: prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA. DSA, MRA, PAD, QISS
58  2011 Renal artery stenosis: comparative assessment by unenhanced renal artery MRA versus contrast-enhanced MRA. RAS, SSFP
59  2011 Simultaneous visualization of nerves and vessels of the lower extremities using magnetization-prepared susceptibility weighted magnetic resonance imaging at 3.0 T. CNR, MR, MRN, SNR
60  2011 [MRI for therapy planning in patients with atrial septum defects]. MRI, SSFP
61  2011 [Non-contrast-Enhanced MR angiography for selective evaluation of the hepatic portal vein]. NCE-MRA
62  2011 [Non-contrast-enhanced MR angiography for selective visualization of the hepatic vein]. NCE-MRA
63  2010 Accuracy of 3T MR angioraphy in vertebral artery stenosis and coincidence with other cerebrovascular stenoses. DSA, MCA, TOF, VA
64  2010 Cardiovascular magnetic resonance in patients with pectus excavatum compared with normal controls. CMR, LD, SD, PI
65  2010 Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. MR, SI, USPIO
66  2010 Comparison of the high relaxivity Gd chelates P1152 and Gd-BOPTA for contrast-enhanced MR angiography in rabbits at 1.5 Tesla and 3.0 Tesla. ---
67  2010 Evaluation of the early enhancement of coronary atherosclerotic plaque by contrast-enhanced MR angiography. SAP, UAP
68  2010 Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison. ---
69  2010 High-resolution 3D non-contrast-enhanced, ECG-gated, multi-step MR angiography of the lower extremities: comparison with contrast-enhanced MR angiography. PVD
70  2010 Intraindividual comparison of contrast-enhanced MRI and unenhanced SSFP sequences of stenotic and non-stenotic pulmonary artery diameters. bSSFP, PA
71  2010 Role of contrast-enhanced magnetic resonance angiography in spinal dural arteriovenous fistula. DSA, SDAVF
72  2009 Coarctation of the abdominal aorta: demonstration of a rare anomaly using contrast-enhanced MR-angiography. MIPs
73  2009 Contrast-enhanced MR angiography is not more accurate than unenhanced 2D time-of-flight MR angiography for determining > or = 70% internal carotid artery stenosis. 2D TOF MRA, CTA, ICA, ROC
74  2009 Contrast-enhanced MR angiography using time resolved interleaved projection sampling with three-dimensional Cartesian phase and slice encoding (TRIPPS). PR
75  2009 Dynamic four-dimensional MR angiography of the chest and abdomen. ---
76  2009 Initial feasibility of a multi-station high resolution three-dimensional dark blood angiography protocol for the assessment of peripheral arterial disease. PAD, SFA, TR-MRA, TSE
77  2009 Myocardial scars are an underestimated cardiovascular burden in patients with internal carotid artery stenosis. CMR, ICA, MI
78  2008 Assessment of craniospinal arteriovenous malformations at 3T with highly temporally and highly spatially resolved contrast-enhanced MR angiography. AVM, CCA
79  2008 Characterization of aneurysm remnants after endovascular treatment: contrast-enhanced MR angiography versus catheter digital subtraction angiography. DSA
80  2008 Feasibility of peripheral contrast-enhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography. DSA
81  2008 Follow-up of coiled cerebral aneurysms at 3T: comparison of 3D time-of-flight MR angiography and contrast-enhanced MR angiography. TOF
82  2008 Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography. ROC
83  2008 High-resolution 3T MR angiography of the carotid arteries: comparison of manual and semiautomated quantification of stenosis. CA
84  2008 MR angiography for detection of pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. AVMs, HTT
85  2008 Peripheral contrast-enhanced MR angiography at 3.0T, improved spatial resolution and low dose contrast: initial clinical experience. ---
86  2008 Unenhanced MR angiography of the thoracic aorta: initial clinical evaluation. MRA, SSFP
87  2007 A clinical MRI investigation of the relationship between kidney volume measurements and renal function in patients with renovascular disease. GFR, RAS, RVD
88  2007 Bilateral ce-MR angiography of the hands at 3.0 T and 1.5 T: intraindividual comparison of quantitative and qualitative image parameters in healthy volunteers. CNR, SNR
89  2007 CE-MR Angiography at 3.0 T Magnetic Field in the Study of Spinal Dural Arteriovenous Fistula. Preliminary Results. TRICKS
90  2007 Comparison of different MRI techniques for the assessment of thoracic aortic pathology: 3D contrast enhanced MR angiography, turbo spin echo and balanced steady state free precession. TSE
91  2007 Effects of doubling and tripling the spatial resolution in standard 3D contrast-enhanced magnetic resonance angiography of carotid artery disease. SNR
92  2007 Estimation of fusiform intracranial aneurysm growth by serial magnetic resonance imaging. IA, MIP
93  2007 Evaluation of carotid artery stenosis with multisection CT and MR imaging: influence of imaging modality and postprocessing. CI, CTA, MIP, MPR, TOF-MRA
94  2007 Gadobenate dimeglumine-enhanced MR angiography: Diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography. DSA
95  2007 Intrinsic signal amplification in the application of 2D SENSE parallel imaging to 3D contrast-enhanced elliptical centric MRA and MRV. MRV, SENSE, SNR
96  2007 Multistation whole-body high-spatial-resolution MR angiography using a 32-channel MR system. MRA, PVD
97  2007 Orthogonal measurement of thoracic aorta luminal diameter using ECG-gated high-resolution contrast-enhanced MR angiography. CI
98  2007 Variable echo time imaging: signal characteristics of 1-M gadobutrol contrast agent at 1.5 and 3T. Gd, SI, vTE
99  2007 [MR imaging and MR angiography of the aorta]. ---
100  2006 A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0M gadobutrol (Gadovist) to intraarterial digital subtraction angiography in body arteries. BR, NPV